Background Background Major depression is
Major depression is associated with activation of the associated with activation of the inflammatory response. inflammatory response.
Aims Aims To examine C-reactive protein
To examine C-reactive protein levels in depression and to determine the levels in depression and to determine the impact of selective serotonin reuptake impact of selective serotonin reuptake inhibitor (SSRI) therapy. inhibitor (SSRI) therapy.
Method
Method A two-part study.In study1, Atwo-part study.In study1, which used a between-subjects design, which used a between-subjects design, C-reactive protein was measured in 32 C-reactive protein was measured in 32 patients (20 currently depressed,12 patients (20 currently depressed,12 euthymic) with a history of DSM^IVmajor euthymic) with a history of DSM^IVmajor depression, all of whom were treated with depression, all of whom were treated with an SSRI, andin a healthycomparison group an SSRI, andin a healthycomparison group ( (n n¼20).Study 2 employed awithin-subject 20).Study 2 employed a within-subject design: C-reactive protein was measured design: C-reactive protein was measured in 20 patients with major depression both in 20 patients with major depression both before and after SSRI treatment. before and after SSRI treatment.
Results

Results In study1,C-reactive protein
In study1,C-reactive protein levels did not differ between the group levels did not differ between the group with with depressive disorder (either currently depressive disorder (either currently depressed or euthymic) treated with SSRIs depressed or euthymic) treated with SSRIs and the healthy group.In study 2 the and the healthy group.In study 2 the protein levels dropped significantly protein levels dropped significantly following treatment with antidepressant following treatment with antidepressant medication. medication.
Conclusions Conclusions Following SSRI treatment
Following SSRI treatment for major depression there is a significant for major depression there is a significant drop in C-reactive protein concentrations drop in C-reactive protein concentrations whether or notthe depression resolves. whether or notthe depression resolves. These findings indicate that antidepressThese findings indicate that antidepressants antsinduce an anti-inflammatoryresponse induce an anti-inflammatoryresponse independent of antidepressant action. independent of antidepressant action.
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C-reactive protein was the first acute-phase C-reactive protein was the first acute-phase protein to be described with a capacity to protein to be described with a capacity to precipitate the somatic C-polysaccharide precipitate the somatic C-polysaccharide of streptococcus pneumonia (Tillett & of streptococcus pneumonia (Tillett & Francis, 1930) . It is a sensitive systemic Francis, 1930) . It is a sensitive systemic marker of inflammation and tissue damage marker of inflammation and tissue damage and is produced by hepatocytes predomiand is produced by hepatocytes predominantly under transcriptional control by the nantly under transcriptional control by the pro-inflammatory cytokine interleukin 6 pro-inflammatory cytokine interleukin 6 (IL-6) (Pepys & Hirschfield, 2003) . The (IL-6) (Pepys & Hirschfield, 2003) . The sole determinant of circulating C-reactive sole determinant of circulating C-reactive protein is the synthesis rate (Vigushin protein is the synthesis rate (Vigushin et al et al, , 1983) , and in general its production 1983), and in general its production increases rapidly in response to a pathoincreases rapidly in response to a pathological stimulus but also falls rapidly upon logical stimulus but also falls rapidly upon resolution of the given stimulus. resolution of the given stimulus.
Major depression has been shown to be Major depression has been shown to be associated with activation of the inflammaassociated with activation of the inflammatory response. These changes include tory response. These changes include increased numbers of peripheral leucocytes, increased numbers of peripheral leucocytes, both monocytes and neutrophils (Maes, both monocytes and neutrophils (Maes, 1999) . 1999). Positive acute-phase proteins Positive acute-phase proteins (including C-reactive protein) are increased (including C-reactive protein) are increased (Sluzewska (Sluzewska et al et al, 1996; Berk , 1996; Berk et al et al, 1997; , 1997; Maes, 1999; Tuglu Maes, 1999; Tuglu et al et al, 2003) , whereas , 2003), whereas negative acute-phase proteins (e.g. albunegative acute-phase proteins (e.g. albumin) are decreased (Maes, 1999) . min) are decreased (Maes, 1999) . This This acute-phase response is an integral part of acute-phase response is an integral part of the inflammatory response and its purpose the inflammatory response and its purpose is to enable protein mobilisation, which is to enable protein mobilisation, which serves to limit tissue damage and stimulate serves to limit tissue damage and stimulate repair (Kushner, 1982) . repair (Kushner, 1982) .
Levels of C-reactive protein have been Levels of C-reactive protein have been used for monitoring many diseases for used for monitoring many diseases for decades. With the advent of highly sensitidecades. With the advent of highly sensitivite tests it has become possible to measure vite tests it has become possible to measure levels of this protein that lie within the levels of this protein that lie within the normal range (Rifai normal range (Rifai et al et al, 1999) . Using , 1999) . Using these high-sensitivity kits, C-reactive these high-sensitivity kits, C-reactive protein may be useful in predicting cardioprotein may be useful in predicting cardiovascular events in patients with coronary vascular events in patients with coronary heart disease (Haverkate heart disease (Haverkate et al et al, 1997; , 1997; Ridker Ridker et al et al, 2000) . Depressed individuals , 2000). Depressed individuals have been shown to be at increased risk of have been shown to be at increased risk of developing angina and myocardial infarcdeveloping angina and myocardial infarction compared with their non-depressed tion compared with their non-depressed counterparts (Dinan, 1999; Rozanski counterparts (Dinan, 1999; Rozanski et al et al, , 1999) . When traditional risk factors for 1999). When traditional risk factors for coronary heart disease are adjusted for, coronary heart disease are adjusted for, depressed individuals have a risk double depressed individuals have a risk double that of the non-depressed population that of the non-depressed population (Rozanski (Rozanski et al et al, 1999) . There is some , 1999). There is some evidence that risk of coronary heart disease evidence that risk of coronary heart disease is associated with a dose-response effect, is associated with a dose-response effect, with higher risk of the disorder in indiviwith higher risk of the disorder in individuals with greater exposure to depression duals with greater exposure to depression (Penninx (Penninx et al et al, 2001) . The Amsterdam , 2001 ). The Amsterdam Longitudinal Ageing study reported a Longitudinal Ageing study reported a relative risk of cardiac mortality of 1.6 relative risk of cardiac mortality of 1.6 associated with depressive symptoms. Howassociated with depressive symptoms. However, this cardiac mortality relative risk inever, this cardiac mortality relative risk increased to 3.8 for those who were clinically creased to 3.8 for those who were clinically depressed (Penninx depressed (Penninx et al et al, 2001 ). The link be-, 2001). The link between depression and coronary heart disease tween depression and coronary heart disease may be mediated through inflammation. may be mediated through inflammation. Atherosclerosis is preceded by inflammation Atherosclerosis is preceded by inflammation with increased production of acute-phase with increased production of acute-phase proteins, including C-reactive protein and proteins, including C-reactive protein and pro-inflammatory cytokines (Libby pro-inflammatory cytokines (Libby et al et al, , 2002; Lesperance 2002; Lesperance et al et al, 2004) . It seems , 2004) . It seems reasonable to assume that depression inreasonable to assume that depression increases the risk of coronary heart disease creases the risk of coronary heart disease through its pro-inflammatory biology. through its pro-inflammatory biology.
The purpose of our study was to The purpose of our study was to examine C-reactive protein levels in deexamine C-reactive protein levels in depression and to determine the impact of pression and to determine the impact of selective serotonin reuptake inhibitor selective serotonin reuptake inhibitor (SSRI) therapy. (SSRI) therapy.
METHOD METHOD Sample Sample
Study 1 used a between-subjects design. Study 1 used a between-subjects design. Thirty-two people with a history of Thirty-two people with a history of DSM-IV DSM-IV major depression (American Psychiatric major depression (American Psychiatric Association, 1994) were recruited. All were Association, 1994) were recruited. All were treated with an SSRI in standard dosages. At treated with an SSRI in standard dosages. At the time of C-reactive protein measurement the time of C-reactive protein measurement all participants had had at least 4 weeks all participants had had at least 4 weeks of therapy. Twelve (4 men, 8 women) were of therapy. Twelve (4 men, 8 women) were defined as euthymic, with a score of 7 or less defined as euthymic, with a score of 7 or less on the Hamilton Rating Scale for Depression on the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) , and had a mean (HRSD; Hamilton, 1960), and had a mean age of 45.3 years (range 23-70). The remainage of 45.3 years (range 23-70). The remaining 20 currently depressed patients ing 20 currently depressed patients (7 men, (7 men, 13 women) had an HRSD score greater 13 women) had an HRSD score greater than 17 and a mean age of 43.3 years than 17 and a mean age of 43.3 years (range 22-71). The comparison group con-(range 22-71). The comparison group consisted of 20 healthy individuals (10 men, 10 sisted of 20 healthy individuals (10 men, 10 women) whose mean age was 37.6 years women) whose mean age was 37.6 years (range 21-58).
(range 21-58).
Study 2 employed a within-subject Study 2 employed a within-subject design. Twenty women were recruited with design. Twenty women were recruited with a mean age of 37.9 years (range 23-56). All a mean age of 37.9 years (range 23-56). All were diagnosed with DSM-IV major dewere diagnosed with DSM-IV major depression with melancholic features and pression with melancholic features and had an HRSD score greater than 17. They had an HRSD score greater than 17. They 4 4 9 4 4 9 had been medication-free for at least 6 had been medication-free for at least 6 weeks at the time of recruitment. Following weeks at the time of recruitment. Following baseline investigation they were treated for baseline investigation they were treated for 3 weeks with either fluoxetine (20 mg), par-3 weeks with either fluoxetine (20 mg), paroxetine (20 mg) or sertraline (50 mg). The oxetine (20 mg) or sertraline (50 mg). The choice of antidepressant was made by the choice of antidepressant was made by the treating clinician. treating clinician. All participants had a full physical All participants had a full physical examination to rule out significant physical examination to rule out significant physical illness, including acute or chronic infections illness, including acute or chronic infections and inflammatory or immune disorders; and inflammatory or immune disorders; individuals were excluded if they had any individuals were excluded if they had any endocrine, immune or metabolic disorder endocrine, immune or metabolic disorder such as an autoimmune disorder, inflamsuch as an autoimmune disorder, inflammatory bowel disease or acquired immunomatory bowel disease or acquired immunodeficiency syndrome. Similarly, participants deficiency syndrome. Similarly, participants who in the past 2 weeks had had an allerwho in the past 2 weeks had had an allergic, infectious or inflammatory response gic, infectious or inflammatory response were excluded from the study. Laboratory were excluded from the study. Laboratory testing was performed on the whole samtesting was performed on the whole sample, including full blood count and renal ple, including full blood count and renal and liver profile. Patients with comorbid and liver profile. Patients with comorbid axis I disorders, including substance misaxis I disorders, including substance misuse, were excluded. use, were excluded.
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
Procedure Procedure
Participants provided a 4 ml sample of Participants provided a 4 ml sample of blood, collected in a serum clot activator blood, collected in a serum clot activator container between 09.00 h and 11.00 h. container between 09.00 h and 11.00 h. Severity of depression was assessed using Severity of depression was assessed using the 17-item version of the HRSD the 17-item version of the HRSD (Hamilton, 1960) on the morning of blood (Hamilton, 1960) on the morning of blood sampling. The levels of C-reactive protein sampling. The levels of C-reactive protein were measured using an immunowere measured using an immunoturbidimetric assay by Olympus (http:// turbidimetric assay by Olympus (http:// www. www. olympus-global.com). This system olympus-global.com). This system was able to detect concentrations of this was able to detect concentrations of this protein as low as 1.57 mg/l. protein as low as 1.57 mg/l.
Data analysis Data analysis
A one-way analysis of variance (ANOVA) A one-way analysis of variance (ANOVA) was performed to determine group differwas performed to determine group differences between both patient groups and the ences between both patient groups and the control group in study 1. In the withincontrol group in study 1. In the withinsubject study, paired subject study, paired t t-tests and Pearson's -tests and Pearson's product moment correlation coefficients product moment correlation coefficients were used as appropriate. All results are were used as appropriate. All results are expressed as mean (s.e.m.) and the data expressed as mean (s.e.m.) and the data were analysed by GraphPad Prism, version were analysed by GraphPad Prism, version 4.0 for Windows (Graph Pad Software, 4.0 for Windows (Graph Pad Software, San Diego, California, USA; http://www. San Diego, California, USA; http://www. graphpad.com graphpad.com). ).
RESULTS RESULTS
Study 1 Study 1
Overall, levels of C-reactive protein did not Overall, levels of C-reactive protein did not differ between the group treated with SSRIs differ between the group treated with SSRIs (whether currently depressed or euthymic) (whether currently depressed or euthymic) and the healthy comparison group (Fig. 1) . and the healthy comparison group (Fig. 1) 
Study 2 Study 2
Following 3 weeks of treatment with an Following 3 weeks of treatment with an SSRI, 2 patients had an HRSD score greater SSRI, 2 patients had an HRSD score greater than 17, and 2 were clinically euthymic than 17, and 2 were clinically euthymic with an HRSD score below 7 (Fig. 2) . with an HRSD score below 7 (Fig. 2) .
Levels of Levels of C-reactive protein dropped C-reactive protein dropped significantly significantly following treatment (Fig. 3): following treatment (Fig. 3) 
DISCUSSION DISCUSSION
The major finding of this study is that The major finding of this study is that following antidepressant treatment there is following antidepressant treatment there is a significant drop in C-reactive protein cona significant drop in C-reactive protein concentrations independent of the resolution of centrations independent of the resolution of depressive symptoms. In our first study we depressive symptoms. In our first study we measured C-reactive protein in patients measured C-reactive protein in patients with major depression who were currently with major depression who were currently depressed and in patients who were euthydepressed and in patients who were euthymic. Patients in both depression groups mic. Patients in both depression groups continued taking their SSRI medication continued taking their SSRI medication for the purpose of this study. Levels of for the purpose of this study. Levels of C-reactive protein did not differ signifi-C-reactive protein did not differ significantly among both groups and healthy cantly among both groups and healthy controls. Previous studies have found controls. Previous studies have found increased levels of C-reactive protein in increased levels of C-reactive protein in people with major depression compared people with major depression compared with healthy individuals, prior to initiation with healthy individuals, prior to initiation of antidepressant therapy (Sluzewska of antidepressant therapy (Sluzewska et al et al, , 1996; Berk 1996; Berk et al et al, 1997; Tuglu , 1997; Tuglu et al et al, 2003) . , 2003). Our study is the first to compare euthymic Our study is the first to compare euthymic and non-euthymic patients both currently and non-euthymic patients both currently receiving treatment. receiving treatment.
Implications Implications
The findings suggest that the inflammatory The findings suggest that the inflammatory response seen in depression may not have a response seen in depression may not have a role in the pathophysiology of depression role in the pathophysiology of depression since it is possible to decrease the inflamsince it is possible to decrease the inflammatory response without any improvement matory response without any improvement in the clinical state. However, the inflamin the clinical state. However, the inflammatory response may have significant matory response may have significant implications for peripheral disorders such implications for peripheral disorders such as coronary heart disease. as coronary heart disease.
Elevation of C-reactive protein Elevation of C-reactive protein
To further clarify the issue we conducted a To further clarify the issue we conducted a study using a within-subject design followstudy using a within-subject design following the same group of patients with major ing the same group of patients with major depression before and after antidepressant depression before and after antidepressant treatment. Pre-treatment C-reactive protein treatment. Pre-treatment C-reactive protein concentrations were higher than those seen concentrations were higher than those seen following treatment. We did not have a following treatment. We did not have a healthy control group for this phase, so healthy control group for this phase, so 4 5 0 4 5 0 it is not possible to say with certainty that it is not possible to say with certainty that the baseline levels were elevated in comparthe baseline levels were elevated in comparison with normal; however, it seems likely ison with normal; however, it seems likely that this was the case. In an earlier study that this was the case. In an earlier study Sluzewska Sluzewska et al et al (1996) measured C-reactive (1996) measured C-reactive protein in 49 in-patients with major depresprotein in 49 in-patients with major depression, all of whom had been drug-free for at sion, all of whom had been drug-free for at least 10 days. A statistically significant difleast 10 days. A statistically significant difference in protein concentration was found ference in protein concentration was found in the patients. Berk in the patients. Berk et al et al (1997) also (1997) also measured C-reactive protein prior to initiameasured C-reactive protein prior to initiation of treatment in patients with major tion of treatment in patients with major depression, and found it to be elevated in depression, and found it to be elevated in the patients relative to healthy participants. the patients relative to healthy participants. In that study increased levels of C-reactive In that study increased levels of C-reactive protein were found to correlate with IL-6 protein were found to correlate with IL-6 concentrations, consistent with the hypothconcentrations, consistent with the hypothesis that major depression is associated with esis that major depression is associated with activation of the immune response. Howactivation of the immune response. However, in our study 2, when C-reactive ever, in our study 2, when C-reactive protein was measured following 3 weeks protein was measured following 3 weeks of antidepressant treatment, levels of this of antidepressant treatment, levels of this protein had significantly reduced. This protein had significantly reduced. This finding was independent of response to finding was independent of response to antidepressant therapy. The data are in antidepressant therapy. The data are in keeping with our first study, which showed keeping with our first study, which showed that the patients with a current episode of that the patients with a current episode of major depression who continued on antimajor depression who continued on antidepressant medication had C-reactive depressant medication had C-reactive protein levels comparable with those in protein levels comparable with those in healthy participants and in patients with healthy participants and in patients with recurrent depressive disorder who were recurrent depressive disorder who were euthymic at the time of the study. euthymic at the time of the study. Rothermundt Rothermundt et al et al (2001) also found (2001) also found that C-reactive protein levels following 2 that C-reactive protein levels following 2 weeks and 4 weeks of treatment did not weeks and 4 weeks of treatment did not differ significantly from those in healthy differ significantly from those in healthy participants, providing further evidence participants, providing further evidence for the anti-inflammatory potential of antifor the anti-inflammatory potential of antidepressants. Hornig depressants. Hornig et al et al (1998) measured (1998) measured C-reactive protein concentrations in uni-C-reactive protein concentrations in unipolar depression and bipolar affective polar depression and bipolar affective disorder; in their study a significant reducdisorder; in their study a significant reduction in the number of participants with tion in the number of participants with levels greater than 6 mg/l was found levels greater than 6 mg/l was found following lithium monotherapy. following lithium monotherapy.
Heart disease and C-reactive Heart disease and C-reactive protein protein
Minor elevations of C-reactive protein are Minor elevations of C-reactive protein are predictive of cardiovascular events in predictive of cardiovascular events in people with coronary heart disease people with coronary heart disease (Haverkate (Haverkate et al et al, 1997) . In a large prospec-, 1997). In a large prospective cohort study from Reykjavik involving tive cohort study from Reykjavik involving 2459 patients and 3969 matched controls, 2459 patients and 3969 matched controls, a single measurement of C-reactive protein a single measurement of C-reactive protein was studied in relation to the 20-year inciwas studied in relation to the 20-year incidence of coronary heart disease. Patients dence of coronary heart disease. Patients with a concentration greater than 2 mg/l with a concentration greater than 2 mg/l had a relative risk of coronary heart disease had a relative risk of coronary heart disease of 1.92 compared with patients with levels of 1.92 compared with patients with levels of the protein in the bottom third (Danesh of the protein in the bottom third (Danesh et al et al, 2004) . The precise mechanism under-, 2004 ). The precise mechanism underlying C-reactive protein levels and adverse lying C-reactive protein levels and adverse outcomes is not clear. It has been suggested outcomes is not clear. It has been suggested that statins, which are commonly used to that statins, which are commonly used to lower cholesterol levels, may reduce syslower cholesterol levels, may reduce systemic inflammation and therefore reduce temic inflammation and therefore reduce C-reactive protein by decreasing levels of C-reactive protein by decreasing levels of atherogenic lipoproteins. However, Nissen atherogenic lipoproteins. However, Nissen et al et al (2005) have demonstrated that the re- (2005) have demonstrated that the reduced rate of progression of atherosclerosis duced rate of progression of atherosclerosis is significantly related to greater reduction is significantly related to greater reduction in levels of atherogenic lipoproteins and in levels of atherogenic lipoproteins and independently related to reductions in independently related to reductions in C-reactive protein. C-reactive protein.
Conclusions Conclusions
Selective serotonin reuptake inhibitor Selective serotonin reuptake inhibitor therapy for major depression results in a therapy for major depression results in a reduction in C-reactive protein levels. This reduction in C-reactive protein levels. This occurs irrespective of clinical outcome. occurs irrespective of clinical outcome. Our findings suggest that Our findings suggest that these drugs these drugs may have benefit as antimay have benefit as anti-inflammatory inflammatory agents even in people without depression agents even in people without depression who have inflammatory conditions. who have inflammatory conditions. 
